Screening lncRNAs with diagnostic and prognostic value for human stomach adenocarcinoma based on machine learning and mRNA‐lncRNA co‐expression network analysis

Background Stomach adenocarcinoma (STAD), is one of the most lethal malignancies around the world. The aim of this study was to find the long noncoding RNAs (lncRNAs) acting as diagnostic and prognostic biomarker of STAD. Methods Base on TCGA dataset, the differentially expressed mRNAs (DEmRNAs) and...

Full description

Saved in:
Bibliographic Details
Published inMolecular genetics & genomic medicine Vol. 8; no. 11; pp. e1512 - n/a
Main Authors Li, Qun, Liu, Xiaofeng, Gu, Jia, Zhu, Jinming, Wei, Zhi, Huang, Hua
Format Journal Article
LanguageEnglish
Published United States John Wiley & Sons, Inc 01.11.2020
John Wiley and Sons Inc
Wiley
Subjects
Online AccessGet full text
ISSN2324-9269
2324-9269
DOI10.1002/mgg3.1512

Cover

Abstract Background Stomach adenocarcinoma (STAD), is one of the most lethal malignancies around the world. The aim of this study was to find the long noncoding RNAs (lncRNAs) acting as diagnostic and prognostic biomarker of STAD. Methods Base on TCGA dataset, the differentially expressed mRNAs (DEmRNAs) and lncRNAs (DElncRNAs) were identified between STAD and normal tissue. The machine learning and survival analysis were performed to evaluate the potential diagnostic and prognostic value of lncRNAs for STAD. We also build the co‐expression network and functional annotation. The expression of selected candidate mRNAs and lncRNAs were validated by Quantitative real‐time polymerase chain reaction (qRT‐PCR) and GSE27342 dataset. GSE27342 dataset were also to perform gene set enrichment analysis. Results A total of 814 DEmRNAs and 106 DElncRNAs between STAD and normal tissue were obtained. FOXD2‐AS1, LINC01235, and RP11‐598F7.5 were defined as optimal diagnostic lncRNA biomarkers for STAD. The area under curve (AUC) of the decision tree model, random forests model, and support vector machine (SVM) model were 0.797, 0.981, and 0.983, and the specificity and sensitivity of the three model were 75.0% and 97.1%, 96.9% and 96%, and 96.9% and 97.1%, respectively. Among them, LINC01235 was not only an optimal diagnostic lncRNA biomarkers, but also related to survival time. The expression of three DEmRNAs (ESM1, WNT2, and COL10A1) and three optimal diagnostic lncRNAs biomarkers (FOXD2‐AS1, RP11‐598F7.5, and LINC01235) in qRT‐PCR validation was were consistent with our integrated analysis. Except for FOXD2‐AS1, ESM1, WNT2, COL10A1, and LINC01235 were upregulated in STAD, which was consistent with our integration results. Gene set enrichment analysis results indicated that DNA replication, Cell cycle, ECM‐receptor interaction, and P53 signaling pathway were four significantly enriched pathways in STAD. Conclusion Our study identified three DElncRNAs as potential diagnostic biomarkers of STAD. Among them, LINC01235 also was a prognostic lncRNA biomarkers.
AbstractList Background Stomach adenocarcinoma (STAD), is one of the most lethal malignancies around the world. The aim of this study was to find the long noncoding RNAs (lncRNAs) acting as diagnostic and prognostic biomarker of STAD. Methods Base on TCGA dataset, the differentially expressed mRNAs (DEmRNAs) and lncRNAs (DElncRNAs) were identified between STAD and normal tissue. The machine learning and survival analysis were performed to evaluate the potential diagnostic and prognostic value of lncRNAs for STAD. We also build the co‐expression network and functional annotation. The expression of selected candidate mRNAs and lncRNAs were validated by Quantitative real‐time polymerase chain reaction (qRT‐PCR) and GSE27342 dataset. GSE27342 dataset were also to perform gene set enrichment analysis. Results A total of 814 DEmRNAs and 106 DElncRNAs between STAD and normal tissue were obtained. FOXD2‐AS1, LINC01235, and RP11‐598F7.5 were defined as optimal diagnostic lncRNA biomarkers for STAD. The area under curve (AUC) of the decision tree model, random forests model, and support vector machine (SVM) model were 0.797, 0.981, and 0.983, and the specificity and sensitivity of the three model were 75.0% and 97.1%, 96.9% and 96%, and 96.9% and 97.1%, respectively. Among them, LINC01235 was not only an optimal diagnostic lncRNA biomarkers, but also related to survival time. The expression of three DEmRNAs (ESM1, WNT2, and COL10A1) and three optimal diagnostic lncRNAs biomarkers (FOXD2‐AS1, RP11‐598F7.5, and LINC01235) in qRT‐PCR validation was were consistent with our integrated analysis. Except for FOXD2‐AS1, ESM1, WNT2, COL10A1, and LINC01235 were upregulated in STAD, which was consistent with our integration results. Gene set enrichment analysis results indicated that DNA replication, Cell cycle, ECM‐receptor interaction, and P53 signaling pathway were four significantly enriched pathways in STAD. Conclusion Our study identified three DElncRNAs as potential diagnostic biomarkers of STAD. Among them, LINC01235 also was a prognostic lncRNA biomarkers.
Stomach adenocarcinoma (STAD), is one of the most lethal malignancies around the world. The aim of this study was to find the long noncoding RNAs (lncRNAs) acting as diagnostic and prognostic biomarker of STAD. Base on TCGA dataset, the differentially expressed mRNAs (DEmRNAs) and lncRNAs (DElncRNAs) were identified between STAD and normal tissue. The machine learning and survival analysis were performed to evaluate the potential diagnostic and prognostic value of lncRNAs for STAD. We also build the co-expression network and functional annotation. The expression of selected candidate mRNAs and lncRNAs were validated by Quantitative real-time polymerase chain reaction (qRT-PCR) and GSE27342 dataset. GSE27342 dataset were also to perform gene set enrichment analysis. A total of 814 DEmRNAs and 106 DElncRNAs between STAD and normal tissue were obtained. FOXD2-AS1, LINC01235, and RP11-598F7.5 were defined as optimal diagnostic lncRNA biomarkers for STAD. The area under curve (AUC) of the decision tree model, random forests model, and support vector machine (SVM) model were 0.797, 0.981, and 0.983, and the specificity and sensitivity of the three model were 75.0% and 97.1%, 96.9% and 96%, and 96.9% and 97.1%, respectively. Among them, LINC01235 was not only an optimal diagnostic lncRNA biomarkers, but also related to survival time. The expression of three DEmRNAs (ESM1, WNT2, and COL10A1) and three optimal diagnostic lncRNAs biomarkers (FOXD2-AS1, RP11-598F7.5, and LINC01235) in qRT-PCR validation was were consistent with our integrated analysis. Except for FOXD2-AS1, ESM1, WNT2, COL10A1, and LINC01235 were upregulated in STAD, which was consistent with our integration results. Gene set enrichment analysis results indicated that DNA replication, Cell cycle, ECM-receptor interaction, and P53 signaling pathway were four significantly enriched pathways in STAD. Our study identified three DElncRNAs as potential diagnostic biomarkers of STAD. Among them, LINC01235 also was a prognostic lncRNA biomarkers.
Stomach adenocarcinoma (STAD), is one of the most lethal malignancies around the world. The aim of this study was to find the long noncoding RNAs (lncRNAs) acting as diagnostic and prognostic biomarker of STAD.BACKGROUNDStomach adenocarcinoma (STAD), is one of the most lethal malignancies around the world. The aim of this study was to find the long noncoding RNAs (lncRNAs) acting as diagnostic and prognostic biomarker of STAD.Base on TCGA dataset, the differentially expressed mRNAs (DEmRNAs) and lncRNAs (DElncRNAs) were identified between STAD and normal tissue. The machine learning and survival analysis were performed to evaluate the potential diagnostic and prognostic value of lncRNAs for STAD. We also build the co-expression network and functional annotation. The expression of selected candidate mRNAs and lncRNAs were validated by Quantitative real-time polymerase chain reaction (qRT-PCR) and GSE27342 dataset. GSE27342 dataset were also to perform gene set enrichment analysis.METHODSBase on TCGA dataset, the differentially expressed mRNAs (DEmRNAs) and lncRNAs (DElncRNAs) were identified between STAD and normal tissue. The machine learning and survival analysis were performed to evaluate the potential diagnostic and prognostic value of lncRNAs for STAD. We also build the co-expression network and functional annotation. The expression of selected candidate mRNAs and lncRNAs were validated by Quantitative real-time polymerase chain reaction (qRT-PCR) and GSE27342 dataset. GSE27342 dataset were also to perform gene set enrichment analysis.A total of 814 DEmRNAs and 106 DElncRNAs between STAD and normal tissue were obtained. FOXD2-AS1, LINC01235, and RP11-598F7.5 were defined as optimal diagnostic lncRNA biomarkers for STAD. The area under curve (AUC) of the decision tree model, random forests model, and support vector machine (SVM) model were 0.797, 0.981, and 0.983, and the specificity and sensitivity of the three model were 75.0% and 97.1%, 96.9% and 96%, and 96.9% and 97.1%, respectively. Among them, LINC01235 was not only an optimal diagnostic lncRNA biomarkers, but also related to survival time. The expression of three DEmRNAs (ESM1, WNT2, and COL10A1) and three optimal diagnostic lncRNAs biomarkers (FOXD2-AS1, RP11-598F7.5, and LINC01235) in qRT-PCR validation was were consistent with our integrated analysis. Except for FOXD2-AS1, ESM1, WNT2, COL10A1, and LINC01235 were upregulated in STAD, which was consistent with our integration results. Gene set enrichment analysis results indicated that DNA replication, Cell cycle, ECM-receptor interaction, and P53 signaling pathway were four significantly enriched pathways in STAD.RESULTSA total of 814 DEmRNAs and 106 DElncRNAs between STAD and normal tissue were obtained. FOXD2-AS1, LINC01235, and RP11-598F7.5 were defined as optimal diagnostic lncRNA biomarkers for STAD. The area under curve (AUC) of the decision tree model, random forests model, and support vector machine (SVM) model were 0.797, 0.981, and 0.983, and the specificity and sensitivity of the three model were 75.0% and 97.1%, 96.9% and 96%, and 96.9% and 97.1%, respectively. Among them, LINC01235 was not only an optimal diagnostic lncRNA biomarkers, but also related to survival time. The expression of three DEmRNAs (ESM1, WNT2, and COL10A1) and three optimal diagnostic lncRNAs biomarkers (FOXD2-AS1, RP11-598F7.5, and LINC01235) in qRT-PCR validation was were consistent with our integrated analysis. Except for FOXD2-AS1, ESM1, WNT2, COL10A1, and LINC01235 were upregulated in STAD, which was consistent with our integration results. Gene set enrichment analysis results indicated that DNA replication, Cell cycle, ECM-receptor interaction, and P53 signaling pathway were four significantly enriched pathways in STAD.Our study identified three DElncRNAs as potential diagnostic biomarkers of STAD. Among them, LINC01235 also was a prognostic lncRNA biomarkers.CONCLUSIONOur study identified three DElncRNAs as potential diagnostic biomarkers of STAD. Among them, LINC01235 also was a prognostic lncRNA biomarkers.
BackgroundStomach adenocarcinoma (STAD), is one of the most lethal malignancies around the world. The aim of this study was to find the long noncoding RNAs (lncRNAs) acting as diagnostic and prognostic biomarker of STAD.MethodsBase on TCGA dataset, the differentially expressed mRNAs (DEmRNAs) and lncRNAs (DElncRNAs) were identified between STAD and normal tissue. The machine learning and survival analysis were performed to evaluate the potential diagnostic and prognostic value of lncRNAs for STAD. We also build the co-expression network and functional annotation. The expression of selected candidate mRNAs and lncRNAs were validated by Quantitative real-time polymerase chain reaction (qRT-PCR) and GSE27342 dataset. GSE27342 dataset were also to perform gene set enrichment analysis.ResultsA total of 814 DEmRNAs and 106 DElncRNAs between STAD and normal tissue were obtained. FOXD2-AS1, LINC01235, and RP11-598F7.5 were defined as optimal diagnostic lncRNA biomarkers for STAD. The area under curve (AUC) of the decision tree model, random forests model, and support vector machine (SVM) model were 0.797, 0.981, and 0.983, and the specificity and sensitivity of the three model were 75.0% and 97.1%, 96.9% and 96%, and 96.9% and 97.1%, respectively. Among them, LINC01235 was not only an optimal diagnostic lncRNA biomarkers, but also related to survival time. The expression of three DEmRNAs (ESM1, WNT2, and COL10A1) and three optimal diagnostic lncRNAs biomarkers (FOXD2-AS1, RP11-598F7.5, and LINC01235) in qRT-PCR validation was were consistent with our integrated analysis. Except for FOXD2-AS1, ESM1, WNT2, COL10A1, and LINC01235 were upregulated in STAD, which was consistent with our integration results. Gene set enrichment analysis results indicated that DNA replication, Cell cycle, ECM-receptor interaction, and P53 signaling pathway were four significantly enriched pathways in STAD.ConclusionOur study identified three DElncRNAs as potential diagnostic biomarkers of STAD. Among them, LINC01235 also was a prognostic lncRNA biomarkers.
Abstract Background Stomach adenocarcinoma (STAD), is one of the most lethal malignancies around the world. The aim of this study was to find the long noncoding RNAs (lncRNAs) acting as diagnostic and prognostic biomarker of STAD. Methods Base on TCGA dataset, the differentially expressed mRNAs (DEmRNAs) and lncRNAs (DElncRNAs) were identified between STAD and normal tissue. The machine learning and survival analysis were performed to evaluate the potential diagnostic and prognostic value of lncRNAs for STAD. We also build the co‐expression network and functional annotation. The expression of selected candidate mRNAs and lncRNAs were validated by Quantitative real‐time polymerase chain reaction (qRT‐PCR) and GSE27342 dataset. GSE27342 dataset were also to perform gene set enrichment analysis. Results A total of 814 DEmRNAs and 106 DElncRNAs between STAD and normal tissue were obtained. FOXD2‐AS1, LINC01235, and RP11‐598F7.5 were defined as optimal diagnostic lncRNA biomarkers for STAD. The area under curve (AUC) of the decision tree model, random forests model, and support vector machine (SVM) model were 0.797, 0.981, and 0.983, and the specificity and sensitivity of the three model were 75.0% and 97.1%, 96.9% and 96%, and 96.9% and 97.1%, respectively. Among them, LINC01235 was not only an optimal diagnostic lncRNA biomarkers, but also related to survival time. The expression of three DEmRNAs (ESM1, WNT2, and COL10A1) and three optimal diagnostic lncRNAs biomarkers (FOXD2‐AS1, RP11‐598F7.5, and LINC01235) in qRT‐PCR validation was were consistent with our integrated analysis. Except for FOXD2‐AS1, ESM1, WNT2, COL10A1, and LINC01235 were upregulated in STAD, which was consistent with our integration results. Gene set enrichment analysis results indicated that DNA replication, Cell cycle, ECM‐receptor interaction, and P53 signaling pathway were four significantly enriched pathways in STAD. Conclusion Our study identified three DElncRNAs as potential diagnostic biomarkers of STAD. Among them, LINC01235 also was a prognostic lncRNA biomarkers.
Author Zhu, Jinming
Wei, Zhi
Li, Qun
Gu, Jia
Liu, Xiaofeng
Huang, Hua
AuthorAffiliation 2 Department of Pathology The 960th Hospital of the PLA Joint Logistics Support Force Jinan China
3 Department of General surgery The 960th Hospital of the PLA Joint Logistics Support Force Jinan China
1 Department of Gastroenterology The 960th Hospital of the PLA Joint Logistics Support Force Jinan China
AuthorAffiliation_xml – name: 2 Department of Pathology The 960th Hospital of the PLA Joint Logistics Support Force Jinan China
– name: 1 Department of Gastroenterology The 960th Hospital of the PLA Joint Logistics Support Force Jinan China
– name: 3 Department of General surgery The 960th Hospital of the PLA Joint Logistics Support Force Jinan China
Author_xml – sequence: 1
  givenname: Qun
  surname: Li
  fullname: Li, Qun
  organization: The 960th Hospital of the PLA Joint Logistics Support Force
– sequence: 2
  givenname: Xiaofeng
  orcidid: 0000-0001-5596-7102
  surname: Liu
  fullname: Liu, Xiaofeng
  email: liuxiaofeng0531@126.com
  organization: The 960th Hospital of the PLA Joint Logistics Support Force
– sequence: 3
  givenname: Jia
  surname: Gu
  fullname: Gu, Jia
  organization: The 960th Hospital of the PLA Joint Logistics Support Force
– sequence: 4
  givenname: Jinming
  surname: Zhu
  fullname: Zhu, Jinming
  organization: The 960th Hospital of the PLA Joint Logistics Support Force
– sequence: 5
  givenname: Zhi
  surname: Wei
  fullname: Wei, Zhi
  organization: The 960th Hospital of the PLA Joint Logistics Support Force
– sequence: 6
  givenname: Hua
  surname: Huang
  fullname: Huang, Hua
  organization: The 960th Hospital of the PLA Joint Logistics Support Force
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33002344$$D View this record in MEDLINE/PubMed
BookMark eNp9ks1u1DAQgCNUREvpgRdAlrgA0rZ24jjJBamqYKlUQOLnbE2cSdaLYy920mVvPAIPwZPxJHh_WrUVNJf455tvJjN5nOxZZzFJnjJ6zChNT_quy45ZztIHyUGapXxSpaLau7HeT45CmNP4lCVnoniU7GdZjMw4P0h-f1Ye0WrbEWPVpw-ngSz1MCONhs66MGhFwDZk4d3V9hLMiKR1nszGHiwJg-tBzQg0aJ0Cr7SNB6SGgA1xlqwvtUViEPwmz9rXx0x_fv7apiTKxTX-WHgMQccQi8PS-W-RBLMKOjxJHrZgAh7t3ofJ17dvvpy9m1x8nJ6fnV5MVC7ydNIyWlIsIaNc0Yy2VORCKV7kUNZVJWhbIk0F5Yym2EINFc8ppI2iOTJo6iw7TM633sbBXC687sGvpAMtNwfOdxJ87IFBybEULCraNC-iUFRVVbeirKBgWcVUHV2vtq7RLmC1BGOuhYzK9eTkenJyPbkIv97Ci7HusVFoBw_mVgW3b6yeyc5dykKIIhMiCl7sBN59HzEMstdBoTFg0Y1BppzH2dMy5xF9fgedu9HHTkeqSnnFKWP0XooLGlPmjEXq2c26rwu--r8icLIFlHcheGyl0gMMccjxM7T5Zyte3om4r207-1IbXP0flO-n02wT8Rev-AJI
CitedBy_id crossref_primary_10_1007_s10142_022_00867_3
crossref_primary_10_1177_15330338231219352
crossref_primary_10_3390_cancers13194919
crossref_primary_10_4236_ojapps_2023_1312175
crossref_primary_10_3390_ijms25105144
crossref_primary_10_1080_14737140_2021_1962297
Cites_doi 10.1038/natur​e13480
10.1016/j.omtn.2019.11.003
10.1890/07-0539.1
10.7150/jca.7691
10.18632/​oncot​arget.15961
10.3322/caac.21208
10.3389/fonc.2019.01030
10.3389/fphar.2019.00150
10.1002/2211-5463.12365
10.1038/s4141​9-018-0275-9
10.1016/j.ctrv.2012.09.007
10.1002/jcb.28754
10.18632/​oncot​arget.17329
10.1007/s1110​2-015-0698-6
10.3892/ol.2018.9050
10.2147/ott.s160196
10.1038/s4138​8-018-0308-y
10.3390/ijms1​7060945
10.1038/s4159​8-019-43924​-x
10.7717/peerj.7722
10.1016/j.gene.2017.12.026
10.1186/s1300​0-015-0310-4
10.3892/ijo.19.5.1003
10.18632/​oncot​arget.15161
10.1371/journ​al.pone.0106748
10.1007/s1327​7-014-2319-9
10.1007/s1327​7-014-2287-0
10.18632/​aging.101843
10.1093/bioin​forma​tics/btp692
10.4161/21541​272.2014.944014
10.3748/wjg.v22.i23.5422
10.1038/s4141​9-018-0877-2
ContentType Journal Article
Copyright 2020 The Authors. published by Wiley Periodicals LLC.
2020 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.
2020. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2020 The Authors. published by Wiley Periodicals LLC.
– notice: 2020 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.
– notice: 2020. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
NPM
7QO
8FD
8FE
8FH
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
GNUQQ
HCIFZ
LK8
M7P
P64
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
RC3
7X8
5PM
ADTOC
UNPAY
DOA
DOI 10.1002/mgg3.1512
DatabaseName Wiley Online Library Open Access
CrossRef
PubMed
Biotechnology Research Abstracts
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Journals
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
ProQuest Natural Science Collection
ProQuest One Community College
ProQuest Central
Engineering Research Database
ProQuest Central Student
SciTech Premium Collection
Biological Sciences
Biological Science Database (Proquest)
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Genetics Abstracts
Biotechnology Research Abstracts
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Biological Science Database
ProQuest SciTech Collection
Biotechnology and BioEngineering Abstracts
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
MEDLINE - Academic
DatabaseTitleList
PubMed
MEDLINE - Academic
Publicly Available Content Database
Publicly Available Content Database

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate LI et al
EISSN 2324-9269
EndPage n/a
ExternalDocumentID oai_doaj_org_article_4e861ba9f2574106999bf689a71391cb
10.1002/mgg3.1512
PMC7667366
33002344
10_1002_mgg3_1512
MGG31512
Genre article
Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID 0R~
1OC
24P
31~
53G
5VS
8-1
8FE
8FH
AAHHS
AAZKR
ABDBF
ACCFJ
ACCMX
ACUHS
ACXQS
ADBBV
ADKYN
ADRAZ
ADZMN
AEEZP
AEQDE
AEUYN
AFKRA
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
AVUZU
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
CCPQU
D-9
DIK
EBS
EJD
GODZA
GROUPED_DOAJ
HCIFZ
HYE
HZ~
IAO
IHR
INH
ITC
KQ8
LK8
M48
M7P
M~E
O9-
OK1
PIMPY
PROAC
RPM
TUS
WIN
AAMMB
AAYXX
AEFGJ
AGXDD
AIDQK
AIDYY
CITATION
PHGZM
PHGZT
PQGLB
PUEGO
NPM
7QO
8FD
ABUWG
AZQEC
DWQXO
FR3
GNUQQ
P64
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
RC3
7X8
5PM
ADTOC
UNPAY
ID FETCH-LOGICAL-c5652-f1080e8a304c030f0656cc475a8b9960f8e02604102efaba9450a2dc05e1adb33
IEDL.DBID UNPAY
ISSN 2324-9269
IngestDate Fri Oct 03 12:53:44 EDT 2025
Sun Oct 26 04:01:25 EDT 2025
Tue Sep 30 17:00:38 EDT 2025
Thu Oct 02 03:56:16 EDT 2025
Sat Oct 11 07:11:34 EDT 2025
Wed Aug 13 03:48:44 EDT 2025
Wed Feb 19 02:29:41 EST 2025
Wed Oct 01 02:41:11 EDT 2025
Thu Apr 24 23:07:12 EDT 2025
Wed Jan 22 16:31:23 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
License Attribution-NonCommercial-NoDerivs
2020 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
cc-by-nc-nd
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5652-f1080e8a304c030f0656cc475a8b9960f8e02604102efaba9450a2dc05e1adb33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-5596-7102
OpenAccessLink https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mgg3.1512
PMID 33002344
PQID 2460663511
PQPubID 2034370
PageCount 14
ParticipantIDs doaj_primary_oai_doaj_org_article_4e861ba9f2574106999bf689a71391cb
unpaywall_primary_10_1002_mgg3_1512
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7667366
proquest_miscellaneous_2448410854
proquest_journals_2924940110
proquest_journals_2460663511
pubmed_primary_33002344
crossref_citationtrail_10_1002_mgg3_1512
crossref_primary_10_1002_mgg3_1512
wiley_primary_10_1002_mgg3_1512_MGG31512
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate November 2020
PublicationDateYYYYMMDD 2020-11-01
PublicationDate_xml – month: 11
  year: 2020
  text: November 2020
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Bognor Regis
– name: Hoboken
PublicationTitle Molecular genetics & genomic medicine
PublicationTitleAlternate Mol Genet Genomic Med
PublicationYear 2020
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Wiley
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
– name: Wiley
References 2019; 7
2017; 8
2019; 9
2016; 19
2018; 645
2019; 11
2019; 10
2015; 10
2016; 17
2020; 19
2019; 120
2014; 64
2018; 9
2018; 8
2014; 5
2010; 26
2013; 39
2001; 19
2020; 513
2014; 35
2014; 9
2018; 11
2007; 88
2018; 16
2018; 37
2016; 22
e_1_2_8_28_1
e_1_2_8_29_1
e_1_2_8_24_1
e_1_2_8_25_1
e_1_2_8_26_1
e_1_2_8_27_1
e_1_2_8_3_1
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_21_1
e_1_2_8_22_1
e_1_2_8_23_1
e_1_2_8_17_1
e_1_2_8_18_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_14_1
e_1_2_8_15_1
e_1_2_8_16_1
e_1_2_8_32_1
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_11_1
e_1_2_8_12_1
e_1_2_8_33_1
e_1_2_8_30_1
References_xml – volume: 10
  start-page: 131
  year: 2015
  article-title: FusionCancer: A database of cancer fusion genes derived from RNA‐seq data
  publication-title: Diagnostic Pathology
– volume: 8
  start-page: 28144
  issue: 17
  year: 2017
  end-page: 28153
  article-title: A novel microRNA signature predicts survival in stomach adenocarcinoma
  publication-title: Oncotarget
– volume: 35
  start-page: 10043
  issue: 10
  year: 2014
  end-page: 10049
  article-title: Biological and clinical implications of endocan in gastric cancer
  publication-title: Tumour Biology
– volume: 37
  start-page: 5020
  issue: 36
  year: 2018
  end-page: 5036
  article-title: Upregulation of the long noncoding RNA FOXD2‐AS1 promotes carcinogenesis by epigenetically silencing EphB3 through EZH2 and LSD1, and predicts poor prognosis in gastric cancer
  publication-title: Oncogene
– volume: 8
  start-page: 279
  issue: 2
  year: 2018
  end-page: 294
  article-title: Identification of key miRNAs and genes associated with stomach adenocarcinoma from The Cancer Genome Atlas database
  publication-title: FEBS Open Bio
– volume: 11
  start-page: 1427
  issue: 5
  year: 2019
  end-page: 1439
  article-title: FoxD2‐AS1 promotes glioma progression by regulating miR‐185-5P/HMGA2 axis and PI3K/AKT signaling pathway
  publication-title: Aging (Albany NY)
– volume: 88
  start-page: 2783
  issue: 11
  year: 2007
  end-page: 2792
  article-title: Random forests for classification in ecology
  publication-title: Ecology
– volume: 64
  start-page: 9
  issue: 1
  year: 2014
  end-page: 29
  article-title: Cancer statistics, 2014
  publication-title: CA: A Cancer Journal for Clinicians
– volume: 7
  year: 2019
  article-title: CD36 identified by weighted gene co‐expression network analysis as a hub candidate gene in lupus nephritis
  publication-title: PeerJ
– volume: 5
  start-page: 221
  issue: 3
  year: 2014
  end-page: 230
  article-title: Serum endocan as a novel prognostic biomarker in patients with hepatocellular carcinoma
  publication-title: Journal of Cancer
– volume: 8
  start-page: 49201
  issue: 30
  year: 2017
  end-page: 49216
  article-title: Identification of aberrantly expressed long non‐coding RNAs in stomach adenocarcinoma
  publication-title: Oncotarget
– volume: 19
  start-page: 194
  issue: 2
  year: 2016
  end-page: 201
  article-title: A comparative analysis of ESM‐1 and vascular endothelial cell marker (CD34/CD105) expression on pituitary adenoma invasion
  publication-title: Pituitary
– volume: 645
  start-page: 76
  year: 2018
  end-page: 84
  article-title: Long non‐coding RNA FOXD2‐AS1 aggravates nasopharyngeal carcinoma carcinogenesis by modulating miR‐363-5p/S100A1 pathway
  publication-title: Gene
– volume: 5
  issue: 4
  year: 2014
  article-title: Long non‐coding RNAs as emerging regulators of differentiation, development, and disease
  publication-title: Transcription
– volume: 17
  start-page: 945
  issue: 6
  year: 2016
  article-title: Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer
  publication-title: International Journal of Molecular Sciences
– volume: 39
  start-page: 60
  issue: 1
  year: 2013
  end-page: 67
  article-title: Current questions for the treatment of advanced gastric cancer
  publication-title: Cancer Treatment Reviews
– volume: 10
  start-page: 150
  year: 2019
  article-title: Analysis of lncRNA‐mediated ceRNA crosstalk and identification of prognostic signature in head and neck squamous cell carcinoma
  publication-title: Frontiers in Pharmacology
– volume: 16
  start-page: 2857
  issue: 3
  year: 2018
  end-page: 2864
  article-title: Wnt2 contributes to the progression of gastric cancer by promoting cell migration and invasion
  publication-title: Oncology Letters
– volume: 11
  start-page: 1571
  year: 2018
  end-page: 1581
  article-title: High expression of COL10A1 is associated with poor prognosis in colorectal cancer
  publication-title: OncoTargets and Therapy
– volume: 22
  start-page: 5422
  issue: 23
  year: 2016
  end-page: 5429
  article-title: Endocan‐expressing microvessel density as a prognostic factor for survival in human gastric cancer
  publication-title: World Journal of Gastroenterology
– volume: 9
  start-page: 849
  issue: 9
  year: 2018
  article-title: TGF‐beta1‐SOX9 axis‐inducible COL10A1 promotes invasion and metastasis in gastric cancer via epithelial‐to-mesenchymal transition
  publication-title: Cell Death & Disease
– volume: 26
  start-page: 493
  issue: 4
  year: 2010
  end-page: 500
  article-title: RNA‐Seq gene expression estimation with read mapping uncertainty
  publication-title: Bioinformatics
– volume: 19
  start-page: 109
  year: 2020
  end-page: 123
  article-title: LncRNA MAGI2‐AS3 is regulated by BRD4 and promotes gastric cancer progression via maintaining ZEB1 overexpression by sponging miR‐141/200a
  publication-title: Molecular Therapy—Nucleic Acids
– volume: 19
  start-page: 1003
  issue: 5
  year: 2001
  end-page: 1007
  article-title: Frequent up‐regulation of WNT2 in primary gastric cancer and colorectal cancer
  publication-title: International Journal of Oncology
– volume: 513
  start-page: 202
  issue: 7517
  year: 2020
  end-page: 209
  article-title: Comprehensive molecular characterization of gastric adenocarcinoma
  publication-title: Nature
– volume: 120
  start-page: 14916
  issue: 9
  year: 2019
  end-page: 14927
  article-title: Bioinformatics profiling utilized a nine immune‐related long noncoding RNA signature as a prognostic target for pancreatic cancer
  publication-title: Journal of Cellular Biochemistry
– volume: 9
  start-page: 7827
  issue: 1
  year: 2019
  article-title: FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics
  publication-title: Scientific Reports
– volume: 9
  start-page: 1030
  year: 2019
  article-title: Novel biomarkers associated with progression and prognosis of bladder cancer identified by co‐expression analysis
  publication-title: Frontiers in Oncology
– volume: 35
  start-page: 10497
  issue: 10
  year: 2014
  end-page: 10502
  article-title: Endothelial cell‐specific molecule‐1: A potential serum marker for gastric cancer
  publication-title: Tumour Biology
– volume: 9
  issue: 9
  year: 2014
  article-title: Discovery and validation of new potential biomarkers for early detection of colon cancer
  publication-title: PLoS One
– volume: 9
  start-page: 233
  issue: 2
  year: 2018
  article-title: The long non‐coding RNA FOXD2‐AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1
  publication-title: Cell Death & Disease
– volume: 8
  start-page: 16811
  issue: 10
  year: 2017
  end-page: 16828
  article-title: Comprehensive investigation of a novel differentially expressed lncRNA expression profile signature to assess the survival of patients with colorectal adenocarcinoma
  publication-title: Oncotarget
– ident: e_1_2_8_2_1
  doi: 10.1038/natur​e13480
– ident: e_1_2_8_13_1
  doi: 10.1016/j.omtn.2019.11.003
– ident: e_1_2_8_6_1
  doi: 10.1890/07-0539.1
– ident: e_1_2_8_20_1
  doi: 10.7150/jca.7691
– ident: e_1_2_8_8_1
  doi: 10.18632/​oncot​arget.15961
– ident: e_1_2_8_22_1
  doi: 10.3322/caac.21208
– ident: e_1_2_8_26_1
  doi: 10.3389/fonc.2019.01030
– ident: e_1_2_8_21_1
  doi: 10.3389/fphar.2019.00150
– ident: e_1_2_8_16_1
  doi: 10.1002/2211-5463.12365
– ident: e_1_2_8_24_1
  doi: 10.1038/s4141​9-018-0275-9
– ident: e_1_2_8_3_1
  doi: 10.1016/j.ctrv.2012.09.007
– ident: e_1_2_8_28_1
  doi: 10.1002/jcb.28754
– ident: e_1_2_8_9_1
  doi: 10.18632/​oncot​arget.17329
– ident: e_1_2_8_18_1
  doi: 10.1007/s1110​2-015-0698-6
– ident: e_1_2_8_32_1
  doi: 10.3892/ol.2018.9050
– ident: e_1_2_8_10_1
  doi: 10.2147/ott.s160196
– ident: e_1_2_8_29_1
  doi: 10.1038/s4138​8-018-0308-y
– ident: e_1_2_8_25_1
  doi: 10.3390/ijms1​7060945
– ident: e_1_2_8_14_1
  doi: 10.1038/s4159​8-019-43924​-x
– ident: e_1_2_8_30_1
  doi: 10.7717/peerj.7722
– ident: e_1_2_8_5_1
  doi: 10.1016/j.gene.2017.12.026
– ident: e_1_2_8_27_1
  doi: 10.1186/s1300​0-015-0310-4
– ident: e_1_2_8_11_1
  doi: 10.3892/ijo.19.5.1003
– ident: e_1_2_8_31_1
  doi: 10.18632/​oncot​arget.15161
– ident: e_1_2_8_23_1
  doi: 10.1371/journ​al.pone.0106748
– ident: e_1_2_8_17_1
  doi: 10.1007/s1327​7-014-2319-9
– ident: e_1_2_8_33_1
  doi: 10.1007/s1327​7-014-2287-0
– ident: e_1_2_8_19_1
  doi: 10.18632/​aging.101843
– ident: e_1_2_8_12_1
  doi: 10.1093/bioin​forma​tics/btp692
– ident: e_1_2_8_7_1
  doi: 10.4161/21541​272.2014.944014
– ident: e_1_2_8_4_1
  doi: 10.3748/wjg.v22.i23.5422
– ident: e_1_2_8_15_1
  doi: 10.1038/s4141​9-018-0877-2
SSID ssj0000884167
Score 2.1888635
Snippet Background Stomach adenocarcinoma (STAD), is one of the most lethal malignancies around the world. The aim of this study was to find the long noncoding RNAs...
Stomach adenocarcinoma (STAD), is one of the most lethal malignancies around the world. The aim of this study was to find the long noncoding RNAs (lncRNAs)...
BackgroundStomach adenocarcinoma (STAD), is one of the most lethal malignancies around the world. The aim of this study was to find the long noncoding RNAs...
Abstract Background Stomach adenocarcinoma (STAD), is one of the most lethal malignancies around the world. The aim of this study was to find the long...
SourceID doaj
unpaywall
pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e1512
SubjectTerms Accuracy
Adenocarcinoma
Algorithms
Annotations
Bioinformatics
Biomarkers
Cancer therapies
Cell cycle
Datasets
Decision trees
Deoxyribonucleic acid
Diagnostic systems
DNA
DNA biosynthesis
Enrichment
Extracellular matrix
Gene expression
Gene set enrichment analysis
Genomes
Learning algorithms
Machine learning
Malignancy
Medical prognosis
mRNA
Network analysis
Non-coding RNA
Original
p53 Protein
Polymerase chain reaction
Signal transduction
Software
Stomach
Support vector machines
Survival
Survival analysis
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELZQD8AF8U9oQebn0Eto4jiOcyyItkLaHoBKvVm2Y28r7XqrtqvCjUfgIXgynoQZOxs1YoELt2zsOFnPZ8_nePINIa-9bwyrWZd3QnQ5-FuTa2ZFLr3mXGsjG4PfDk8OxcER_3BcH19L9YUxYUkeOHXcDndSlEa3HrDFYf0ChMZ4IVsNq6u2tAZn30K21xZTcQ6WuJ3WrKSECrYzn06rN-jeRg4o6vSvI5e_x0jeWoYz_fVKz2ZjHhsd0d5dcqdnkHQ3Pfk9csOF--TmpN8jf0B-fLIYSwMuic6C_Xi4e0HxZSvtUlAdXEV16CgGZvU_UfDbUWCvNGbso8AH59qeUA1zEri6c2gXTlB0eB1dBDqPAZiO9hknprG9Odzp57fv6ZbULuDYfemjbAMNKdocaiYNlIfkaO_953cHeZ-LIbdA-VjuMRbRSV0V3MK84IG5CGt5U2tpUODFS4fqZGAh5rwGe_G60KyzRe1K3ZmqekQ2wiK4J4QyY4zzhjNnJbdtYxq4rvC8rZzlwrQZ2V4ZSNleqBzzZcxUklhmCm2p0JYZeTlUPUvqHOsqvUUrDxVQUDueAJipHmbqXzDLyNYKI6of5ReKcREZW1muL8a1LUeClZEXQzEMX9yT0cEtltgEB6QC7-UZeZwQNzxoVSGj4lDSjLA4-ifjknB6EiXCG8zmKkRGXg2o_VsHbUc8_7mGmuzvV3jw9H_05Sa5zfCtRfyic4tsXJ4v3TOgdpfmeRzFvwCRr0-v
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELbKVgIuiDcpBZnHoZfQrOM4yQGhFvUhpF2hQqXeItuxt0i7znbbFfBv-KnMOE6kiKW3JJ44cTzj-WKPvyHkvbW5Yhmr41qIOgZ_q2LJtIgLKzmXUhW5wr3Dk6k4PedfLrKLLTLt9sJgWGU3JvqBum40zpHvM_xR4OitPi2vYswahaurXQoNGVIr1B89xdgdss2QGWtEtg-Ppl_P-lkXsClAIHlHMZSw_cVsln5AtzdwTJ6_fxPo_Dd28t7aLeXvn3I-H-Jb76COH5IHAVnSg1YVHpEt4x6Tu5Owdv6E_PmmMcYGXBWdO302PbimOAlL6zbYDu6i0tUUA7bCKRKBGwqolvpMfhRw4kLqSyphrAIXuIJ64QJFR1jTxtGFD8w0NGSimPn6FvCkuH0g1U1sfoXIW0ddG4EOUi0vylNyfnz0_fNpHPIzxBpgIIstxieaQqYJ1zBWWEAzQmueZ7JQSPpiC4OMZRwwjLFSyZJniWS1TjIzlrVK02dk5BpnXhDKlFLGKs6MLrguc5XDfYnlZWo0F6qMyF7XOZUO5OWYQ2NetbTLrMJ-rLAfI_K2F122jB2bhA6xh3sBJNn2F5rVrAo2W3FTiDG8toVhDRohAEsrK4pSwo99OdYqIrudflTB8q8rxoVHcePx5uJejSPypi8Gk8Z1GulMs8YqOGgpYGEekeettvUvmqaIsjiU5AM9HLRkWOJ-XHra8BwzvAoRkXe9xt72gfa8Lv9fopqcnKR4sHN7O1-S-wznKPz-zV0yulmtzSsAcjfqdbDOv7kjSuo
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELZKkYAL4p9AQebn0EvajeM4yQGhgmgrpO0BWKm3yHbsLVLWKduuaG88Ag_Bk_EkzDhORMTCiVsSj53EM_Z8jiffEPLS2lyxjNVxLUQdg79VsWRaxIWVnEupilzhv8PTI3E44--Ps-MN0ufYDB14tnZph_mkZstm5-LL5WsY8K8CgejuYj5Pd9BzXSFXwUGVmMFhGlC-n5AL3FvLe16h32uMvJEn7V-HNP8MmLy-cqfy8qtsmjGo9V5p_xa5GeAk3ev0f5tsGHeHXJuGDfO75MdHjYE14J9o4_SHo70zil9ead1F2EEtKl1NMUornCL7t6EAZalP30cBHC6kPqESJijwe0toFy5Q9H41bR1d-GhMQ0P6iblvbwF3-vnte3dLqls4Nhch5NZR14Weg2RHiHKPzPbffXp7GIfEDLEG_Mdii4GJppDphGuYJCzAGKE1zzNZKGR7sYVBqjIO4MVYqWTJs4lktZ5kJpG1StP7ZNO1zjwklCmljFWcGV1wXeYqh3oTy8vUaC5UGZHtXkGVDqzlmDyjqTq-ZVahLivUZUSeD6KnHVXHOqE3qOVBANm1_YV2Oa_CYK24KUQCj21hPoOXEACilRVFKWFFXyZaRWSrt5Gqt9iKceHhW5KsL8aFLke0FZFnQzGMZdygkc60K2yCg6UCCOYRedBZ3PCgaYrwikNJPrLF0ZuMS9znE88XnmNqVyEi8mKw2n910La3579LVNODgxQPHv2PvnxMbjD8hOF_79wim-fLlXkCOO9cPfWj-Bdyc1ZK
  priority: 102
  providerName: Scholars Portal
– databaseName: Wiley Online Library Open Access
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NbtQwELZKkYAL4p9AQebn0Eto4kycRJwKoq2QtkJApd4i27G3SLtOtdsVcOMReAiejCdhxskGRSyIWxKP7SSe8Xxxxt8w9ty5QotcNHEjZROjv9WxEkbGpVMASumy0LR3eHIsj07g7Wl-usVervfCdPwQw4IbWUaYr8nAlV7u_SYNnU-n2QvyV5fY5RRxDKm3gHfDAguaD4KNIiSXExBXQlZrZqFE7A21R_4o0PZvwpp_hkxeXflz9fWzms3GsDb4pYMb7HoPKPl-pwE32Zb1t9iVSf_L_Db78cFQaA16KD7z5v3x_pLT2itvuhg7rMWVbzjFafWnxP9tOYJZHhL4cYSHc2XOuMIpCj3fAtvFC5z8X8Nbz-chHtPyPgHFNLQ3x55-fvvedclNi8f2Sx9067nvgs9RsqNEucNODt58fH0U96kZYoMIUMSOQhNtqbIEDE4TDoGMNAaKXJWa-F5caYmsDBC-WKe0qiBPlGhMkttUNTrL7rJt33p7n3GhtbZOg7CmBFMVusB6iYMqswakriK2ux6g2vS85ZQ-Y1Z3jMuiprGsaSwj9nQQPe_IOjYJvaJRHgSIXztcaBfTujfXGmwpU7xthzMaPoREGK2dLCuF3_RVanTEdtY6UvdGv6wFyADg0nRzMX3qAuGtiD0ZitGa6ReN8rZdUROAWoswGCJ2r9O44UazjAAWYEkx0sXRk4xL_KezwBheUHJXKSP2bNDaf72g3aDPf5eoJ4eHGR08-H_Rh-yaoKWKsI1zh21fLFb2EeK5C_042O0v26xJ1Q
  priority: 102
  providerName: Wiley-Blackwell
Title Screening lncRNAs with diagnostic and prognostic value for human stomach adenocarcinoma based on machine learning and mRNA‐lncRNA co‐expression network analysis
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmgg3.1512
https://www.ncbi.nlm.nih.gov/pubmed/33002344
https://www.proquest.com/docview/2460663511
https://www.proquest.com/docview/2924940110
https://www.proquest.com/docview/2448410854
https://pubmed.ncbi.nlm.nih.gov/PMC7667366
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mgg3.1512
https://doaj.org/article/4e861ba9f2574106999bf689a71391cb
UnpaywallVersion publishedVersion
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2324-9269
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000884167
  issn: 2324-9269
  databaseCode: KQ8
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2324-9269
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000884167
  issn: 2324-9269
  databaseCode: DOA
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 2324-9269
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000884167
  issn: 2324-9269
  databaseCode: ABDBF
  dateStart: 20140501
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 2324-9269
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000884167
  issn: 2324-9269
  databaseCode: DIK
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2324-9269
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000884167
  issn: 2324-9269
  databaseCode: M~E
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 2324-9269
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000884167
  issn: 2324-9269
  databaseCode: RPM
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 2324-9269
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000884167
  issn: 2324-9269
  databaseCode: BENPR
  dateStart: 20130501
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 2324-9269
  dateEnd: 20250930
  omitProxy: true
  ssIdentifier: ssj0000884167
  issn: 2324-9269
  databaseCode: M48
  dateStart: 20130501
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
– providerCode: PRVWIB
  databaseName: KBPluse Wiley Online Library: Open Access
  customDbUrl:
  eissn: 2324-9269
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000884167
  issn: 2324-9269
  databaseCode: AVUZU
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://www.kbplus.ac.uk/kbplus7/publicExport/pkg/559
  providerName: Wiley-Blackwell
– providerCode: PRVWIB
  databaseName: Wiley Online Library Open Access
  customDbUrl:
  eissn: 2324-9269
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000884167
  issn: 2324-9269
  databaseCode: 24P
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwELbYVoK98H4Elso8DntJaR3HSY5dtA8htaoWKi2nYDt2F22bVt1WPE78BH4Ev4xfwozjRhQKQuISJfHEia3xzBd7_A0hz61NFItZERZCFCH4WxVKpkWYWsm5lCpNFO4d7g_EyYi_OovPfJ5T3AtT8UPUE244Mpy9xgE-L2xl5_3qPnsxHY-jNvqsHdIUMYDxBmmOBsPeW5dSjvEwYyJb8wn9LL_hhRxZ_zaE-Xug5LVVOZefPsjJZBPMOm90dIO8W7ejCkK5aK-Wqq0__0Lx-B8NvUmue6RKe5Vq3SJXTHmbXO37tfg75NtrjTE74PropNSng94lxUldWlTBe_AUlWVBMQDMXyKxuKGAkqnLDEgBd06lPqcSbB-41AXUCzcoOtaCzko6dYGehvrMFmNX3xTe9P3L1-qVVM_g3Hz00bwlLauodpCsuFbuktHR4ZuXJ6HP-RBqgJYstBjzaFIZdbgG-2MBIQmteRLLVCGRjE0NsqBxwEXGSiUzHnckK3QnNl1ZqCi6RxrlrDQPCGVKKWMVZ0anXGeJSuC5juVZZDQXKgvI_loHcu0J0TEvxySvqJxZjr2eY68H5GktOq9YQLYJHaAi1QJI3O1uzBbj3NuBnJtUdOGzLZhKaIQAfK6sSDOZABTvahWQvbUa5t6aXOaMC4cMu93txfgPzRHIBeRJXQxmAtd-ZGlmK6yCpxx3mvCA3K-Uuv7QKELkxqEk2VD3jZZslpTvzx0VeYJZY4UIyLN6YPytg_adnv9ZIu8fH0d48vCfKnxEdhlOf7itoXuksVyszGPAiEvVIjuMD1ukeXA4GJ623EwLHPs8bXkL8QP1JnAV
linkProvider Unpaywall
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fT9swELcQSGMvaP8Xxjbvn8RLoHVcJ3lAE2xAGbSaGEi8ZbZjl0lt0rVUjG-zT7LPtjvHiVSt4423NnacOHe-38_2-Y6Q99bGinVYHuZC5CHgrQol0yJMrORcSpXECs8O9_qie86_XHQulsif-iwMulXWNtEZ6rzUuEa-zXCiwBGtPo5_hpg1CndX6xQa0qdWyHdciDF_sOPY3FzDFG66c_QZ5P2BsYP9s0_d0GcZCDWQGRZa9LIziYR5vQaNt4DJQmsed2SiMHSJTQzG3eKAxMZKJVPeaUmW61bHtGWucEEUIGCFRzyFyd_K3n7_62mzygNjGBhPXIc0arHt0WAQbSHMzgGhyxewiOT-66u5OivG8uZaDofzfNoB4sEDsuaZLN2tVO8hWTLFI3Kv5_fqH5Pf3zT69AA00mGhT_u7U4qLvjSvnPvgLiqLnKKDmP-LgccNBRZNXeZACrx0JPUllWAbAXIn0C5coAi8OS0LOnKOoIb6zBcD194InhRWD6S6DM0v7-lb0KLyeIdaVRyWJ-T8TiT1lCwXZWGeE8qUUsYqzoxOuE5jFcN9LcvTyGguVBqQzVo4mfbB0jFnxzCrwjyzDOWYoRwD8rapOq4ihCyqtIcSbipgUG93oZwMMm8jMm4S0YbXtmBGoRMCuLuyIkllDDS9rVVANmr9yLylmWaMC8ca2-3Fxc2wCcibphhMCO4LycKUM2yCg5YC9-YBeVZpW_OiUYSsjkNJPKeHcz2ZLyl-XLow5TFmlBUiIO8ajb3tA206Xf5_jax3eBjhj_Xb-_marHbPeifZyVH_-AW5z3B9xJ0d3SDLV5OZeQkk8kq98iOVku93bRz-AtOuhno
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fT9swELcQSGwv0_4vG9u8fxIvoa3rOukDmmBQYKwVYkPiLbMdu0xqna6lYnybfZ59qt05TqRqHW-8tbHjxLnz_X62z3eEvLc2UazD8jgXIo8Bb1UsmRZxaiXnUqo0UXh2uD8Qh2f883nnfIX8qc7CoFtlZRO9oc4LjWvkDYYTBY5o1bDBLeJkr_dx8jPGDFK401ql05AhzUK-7cONhUMex-b6CqZzs-2jPZD9B8Z6-98-HcYh40Csgdiw2KLHnUklzPE1aL8FfBZa86QjU4VhTGxqMAYXB1Q2VirZ5Z2mZLludkxL5goXRwEO1nDzC4zE2u7-4OS0XvGB8QzsJ6nCGzVZYzwctrcQchdA0ecOWEZ4__XbvDN3E3l9JUejRW7twbF3n9wLrJbulGr4gKwY95Cs98O-_SPy-6tG_x6ASTpy-nSwM6O4AEzz0tEP7qLS5RSdxcJfDEJuKDBq6rMIUuCoY6kvqAQ7CfA7hXbhAkUQzmnh6Ng7hRoasmAMfXtjeFJcPpDqIja_gtevo670fodaZUyWx-TsViT1hKy6wplnhDKllLGKM6NTrruJSuC-puXdttFcqG5ENivhZDoETsf8HaOsDPnMMpRjhnKMyNu66qSMFrKs0i5KuK6AAb79hWI6zIK9yLhJRQte24JJhU4I4PHKirQrE6DsLa0islHpRxaszixjXHgG2WotL66HUETe1MVgTnCPSDpTzLEJDloKPJxH5GmpbfWLttvI8DiUJAt6uNCTxRL348KHLE8wu6wQEXlXa-xNH2jT6_L_a2T9g4M2_nh-cz9fk3UwEtmXo8HxC3KX4VKJP0a6QVYvp3PzEvjkpXoVBiol32_bNvwF_cKKqQ
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwELagKwEX3o_AgszjsJeU1nGc5FgQuyukVgiotJyC7dhdROtW3VY8TvwEfgS_jF_CjO1GFBaExC2JJ3ZsjWe-2ONvCHlkbaFYzpq0EaJJwd-qVDIt0tJKzqVUZaHw7PBwJA7H_PlRfhTznOJZmMAP0S644czw9hon-KKxwc7H3X32eDaZZF30WWfJjsgBjHfIznj0YvDGp5RjPK2YqDZ8Qj_Lb3khT9Z_GsL8PVDy_Not5KcPcjrdBrPeG-1fIm83_QhBKO-765Xq6s-_UDz-R0cvk4sRqdJBUK0r5IxxV8m5YdyLv0a-vdIYswOuj06dfjkanFBc1KVNCN6Dt6h0DcUAsHiLxOKGAkqmPjMgBdw5k_qYSrB94FKXUC88oOhYGzp3dOYDPQ2NmS0mvr4ZtPT9y9fQJNVzuDYfYzSvoy5EtYNk4Fq5Tsb7z14_PUxjzodUA7RkqcWYR1PKrMc12B8LCElozYtclgqJZGxpkAWNAy4yVipZ8bwnWaN7uenLRmXZDdJxc2duEcqUUsYqzowuua4KVcB7PcurzGguVJWQvY0O1DoSomNejmkdqJxZjaNe46gn5EEruggsIKcJPUFFagWQuNs_mC8ndbQDNTel6MNnWzCV0AkB-FxZUVayACje1yohuxs1rKM1OakZFx4Z9vunF-M_NEcgl5D7bTGYCdz7kc7M11gFLzmeNOEJuRmUuv3QLEPkxqGk2FL3rZ5sl7h3x56KvMCssUIk5GE7Mf42QHtez_8sUQ8PDjK8uP1PFd4hFxguf_ijobuks1quzV3AiCt1L9qBH9T1a9U
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Screening+lncRNAs+with+diagnostic+and+prognostic+value+for+human+stomach+adenocarcinoma+based+on+machine+learning+and+mRNA%E2%80%90lncRNA+co%E2%80%90expression+network+analysis&rft.jtitle=Molecular+genetics+%26+genomic+medicine&rft.au=Qun+Li&rft.au=Xiaofeng+Liu&rft.au=Jia+Gu&rft.au=Jinming+Zhu&rft.date=2020-11-01&rft.pub=Wiley&rft.eissn=2324-9269&rft.volume=8&rft.issue=11&rft.epage=n%2Fa&rft_id=info:doi/10.1002%2Fmgg3.1512&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_4e861ba9f2574106999bf689a71391cb
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2324-9269&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2324-9269&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2324-9269&client=summon